期刊文献+

槲皮素对SW620细胞迁移和侵袭的影响 被引量:6

Effects of quercetin on the migration and invasion of SW620 cells
下载PDF
导出
摘要 目的探索槲皮素对结直肠癌细胞SW620迁移和侵袭的影响。方法不同浓度(0、25、50、100μmol/L)槲皮素处理SW620细胞后,MTT法检测细胞存活率,Transwell法检测细胞迁移和侵袭,RT-PCR、Western blot分别检测STAT3 mRNA、蛋白表达。结果槲皮素呈剂量和时间依赖性地降低SW620细胞存活率、STAT3 mRNA表达。最佳浓度、处理时间分别为50μmol/L、48 h,细胞迁移和侵袭显著降低(P<0.05)。敲低STAT3,SW620细胞存活率、迁移和侵袭数目明显减少(P<0.05)。STAT3过表达显著逆转槲皮素对细胞存活率、迁移和侵袭的抑制作用(P<0.05)。结论槲皮素可通过调控STAT3表达来抑制SW620细胞迁移和侵袭。 AIM To explore the effects of quercetin on migration and invasion of colorectal cancer SW620 cells.METHODS SW620 cells were treated with different concentrations(0, 25, 50, 100 μmol/L) of quercetin, after which cell viability was detected by MTT assay, cell migration and invasion were detected by Transwell assay, STAT3 mRNA and protein expressions were detected by RT-PCR and Western blot, respectively.RESULTS Quercetin decreased SW620 cell viability and STAT3 mRNA expression in dose-dependent and time-dependent mannerso the optimal concentration and treatment time were determined to be 50 μmol/L and 48 h, repsectively, along with significantly reduced cell migration and invasion(P<0.05);and the cell viability,migration and invasion of SW620 cells were significantly redued when STAT3 was knocked down(P<0.05). The overexpression of STAT3 obviously reversed the inhibitory effects of quercetin on cell viability, migration and invasion(P<0.05). CONCLUSION Quercetin can inhibit the migration and invasion of SW620 cells by regulating STAT3 expression.
作者 黄文涛 周进 王贵玉 HUANG Wen-tao;ZHOU Jin;WANG Gui-yu(Department of Pharmacy,The First Hospital of Wuhan,Wuhan 430000,China;Department of Oncology,Cancer Hospital Affiliated to Harbin Medical University,Harbin 150040,China)
出处 《中成药》 CAS CSCD 北大核心 2019年第9期2079-2083,共5页 Chinese Traditional Patent Medicine
关键词 槲皮素 SW620细胞 迁移 侵袭 STAT3 quercetin SW620 cells migration invasion STAT3
  • 相关文献

参考文献6

二级参考文献158

  • 1何立丽,孙桂芝.孙桂芝教授治疗大肠癌经验[J].辽宁中医药大学学报,2009,11(4):97-99. 被引量:30
  • 2Ridel C. Radiotherapy: Preoperative chemoradiotherapy for rectal cancer[J]. Nat Rev Clin Oncol, 2010,7:129-130.
  • 3Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer [J]. N Engl J Med, 2006,355: 1114-1123.
  • 4Huerta S, Gao X, Saha D. Mechanisms of resistance to ionizing radiation in rectal eaneer[J]. Expert Rev Mol Diagn, 2009,9: 469-480.
  • 5Grade M, Wolff HA, Gaedcke J, et al. The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies [ J ]. Langenbecks Arch Surg, 2012,397 : 543-555.
  • 6Huerta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer [J]. Expert Rev Mol Diagn, 2008,8 : 277-288.
  • 7Dutreix M, Cosset JM, Sun JS. Molecular therapy in support to radiotherapy[J]. Mutat Res, 2010,704: 182-189.
  • 8Bourguignon MH, Gisone PA, Perez MR, et al. Genetic and epigenetic features in radiation sensitivity. Part ]I : implications for clinical practice and radiation protection [J]. Eur J Nucl Med Mol Imaging, 2005,32 : 351-368.
  • 9Chistiakov DA, Voronova NV, Chistiakov PA. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients[J]. Acta oncol, 2008,47:809-824.
  • 10Vogelstein B, Lane D, Levine AJ. Surfing the P53 network[J]. Nature, 2000,408 : 307-310.

共引文献100

同被引文献95

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部